AGP Executive Report
Last update: 8 hours agoMedical Cannabis in Pregnancy (Arkansas): UAMS researchers published a population-level look at how pregnant Arkansans buy medical cannabis, tracking 72,992 pregnancies (2019–2022) and finding 1.62% involved purchases, with about two-thirds continuing before and during pregnancy. Drug Policy & Harm Reduction (NYC): The Mamdani administration made a cash-for-syringes pilot permanent, keeping the Community Syringe Redemption Program funded at $3M in the new budget, paying 20 cents per returned syringe (up to 50/day). Cannabis Research Tools (Forensics): NIST expanded its mass-spectra “chemical fingerprints” library (Standard Reference Database 1A) to help identify unknown substances across drugs, food, cosmetics, and the environment. Sleep & Cannabinoids (Health): Multiple pieces focus on sleep support, including guidance on magnesium and melatonin, plus cannabinoid-related sleep angles like CBN and cannabis-infused tea claims. Local Cannabis Enforcement/Seizures: CANU reported major mid-year seizures (519.49kg narcotics, 35 illegal firearms, 699 rounds) as part of ongoing anti-drug operations. Pregnancy + Cannabis Education: Coverage also highlights communication gaps between cancer survivors and providers on cannabis use, underscoring the need for clearer guidance.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
